Details
Stereochemistry | ACHIRAL |
Molecular Formula | C9H18N4 |
Molecular Weight | 182.266 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CCN(CCNC(N)=N)CC1
InChI
InChIKey=WQVAYGCXSJMPRT-UHFFFAOYSA-N
InChI=1S/C9H18N4/c1-8-2-5-13(6-3-8)7-4-12-9(10)11/h2H,3-7H2,1H3,(H4,10,11,12)
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/5420832
Sources: https://www.ncbi.nlm.nih.gov/pubmed/5420832
Guanacline was studied in the treatment of hypertension. However, information about the current use of this compound is not available.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Guanacline, a new hypotensive drug. | 1969 Jan 25 |
|
Clinical experiences with Leron (guanacline) in the treatment of hypertension. | 1970 May 9 |
|
Species and structural specificity of the lipopigment accumulation and neuronal destruction induced by N-(2-guanidinoethyl)-4-methyl-1,2,5,6-tetrahydropyridine (guanacline). | 1986 Sep 24 |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m221
Created by
admin on Fri Dec 15 14:59:05 GMT 2023 , Edited by admin on Fri Dec 15 14:59:05 GMT 2023
|
PRIMARY | Merck Index | ||
|
SUB07979MIG
Created by
admin on Fri Dec 15 14:59:05 GMT 2023 , Edited by admin on Fri Dec 15 14:59:05 GMT 2023
|
PRIMARY | |||
|
C004943
Created by
admin on Fri Dec 15 14:59:05 GMT 2023 , Edited by admin on Fri Dec 15 14:59:05 GMT 2023
|
PRIMARY | |||
|
C166589
Created by
admin on Fri Dec 15 14:59:05 GMT 2023 , Edited by admin on Fri Dec 15 14:59:05 GMT 2023
|
PRIMARY | |||
|
15102
Created by
admin on Fri Dec 15 14:59:05 GMT 2023 , Edited by admin on Fri Dec 15 14:59:05 GMT 2023
|
PRIMARY | |||
|
2S93M1DW13
Created by
admin on Fri Dec 15 14:59:05 GMT 2023 , Edited by admin on Fri Dec 15 14:59:05 GMT 2023
|
PRIMARY | |||
|
100000084451
Created by
admin on Fri Dec 15 14:59:05 GMT 2023 , Edited by admin on Fri Dec 15 14:59:05 GMT 2023
|
PRIMARY | |||
|
1463-28-1
Created by
admin on Fri Dec 15 14:59:05 GMT 2023 , Edited by admin on Fri Dec 15 14:59:05 GMT 2023
|
PRIMARY | |||
|
CHEMBL1160385
Created by
admin on Fri Dec 15 14:59:05 GMT 2023 , Edited by admin on Fri Dec 15 14:59:05 GMT 2023
|
PRIMARY | |||
|
2150
Created by
admin on Fri Dec 15 14:59:05 GMT 2023 , Edited by admin on Fri Dec 15 14:59:05 GMT 2023
|
PRIMARY | |||
|
DTXSID90163350
Created by
admin on Fri Dec 15 14:59:05 GMT 2023 , Edited by admin on Fri Dec 15 14:59:05 GMT 2023
|
PRIMARY | |||
|
3454
Created by
admin on Fri Dec 15 14:59:05 GMT 2023 , Edited by admin on Fri Dec 15 14:59:05 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)